SAG
CVS icon

SageView Advisory Group’s CVS Health CVS Stock Holding History

SageView Advisory Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$992K Sell
9,591
-817
-8% -$72.9K 0.03% 248
2026
Q1 		$748K Sell
10,408
-1,492
-13% -$115K 0.03% 271
2025
Q4 		$944K Sell
11,900
-3,777
-24% -$298K 0.03% 263
2025
Q3 		$1.18M Buy
15,677
+414
+3% +$28.4K 0.04% 244
2025
Q2 		$910K Buy
15,263
+1,424
+10% +$93.4K 0.03% 258
2025
Q1 		$938K Sell
13,839
-117
-0.8% -$7K 0.04% 237
2024
Q4 		$626K Buy
13,956
+1,739
+14% +$97.6K 0.03% 302
2024
Q3 		$768K Sell
12,217
-2,940
-19% -$172K 0.04% 232
2024
Q2 		$895K Buy
15,157
+625
+4% +$39.1K 0.04% 240
2024
Q1 		$1.16M Sell
14,532
-2,704
-16% -$207K 0.06% 178
2023
Q4 		$1.27M Sell
17,236
-306
-2% -$21.8K 0.05% 214
2023
Q3 		$1.22M Buy
17,542
+1,149
+7% +$81.4K 0.07% 180
2023
Q2 		$1.13M Buy
16,393
+5,855
+56% +$417K 0.06% 201
2023
Q1 		$783K Buy
10,538
+1,243
+13% +$104K 0.05% 247
2022
Q4 		$866K Buy
+9,295
New +$897K 0.07% 170

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

SageView Advisory Group's CVS Position: Q2 2026 in Review

SageView Advisory Group reduced its CVS Health (CVS) stake by 7.8% in Q2 2026, selling an estimated $72.9K and leaving 9,591 shares worth $992K. The position accounts for 0.03% of the portfolio, ranked #248.

SageView Advisory Group first reported a position in CVS in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.27M in Q4 2023. 2,069 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • SageView Advisory Group held 9,591 shares of CVS Health worth $992K as of Q2 2026.
  • SageView Advisory Group sold 817 CVS Health shares in Q2 2026, an estimated $72.9K.
  • CVS Health made up 0.03% of SageView Advisory Group's portfolio in Q2 2026, its #248 holding.
  • SageView Advisory Group first reported a position in CVS Health in Q4 2022 and has held it in 15 quarters since.
  • SageView Advisory Group's CVS Health position peaked at $1.27M in Q4 2023.
  • 2,069 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on SageView Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.